Marquis Who's Who Honors Kevin T. McHenry, PhD, for Expertise in Medical Science
Press Release January 24, 2025
Kevin T. McHenry, PhD, is a leading specialist in oncology research
img img

JERICHO, NY, January 24, 2025 /24-7PressRelease/ -- Kevin T. McHenry, PhD, has been recognized for his inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. McHenry has established himself as a distinguished figure in the field of oncology research over an impressive career spanning more than 15 years. Currently serving as a senior medical science liaison at Grail since 2023, Dr. McHenry plays a pivotal role in engaging, educating, and supporting providers on the proper utilization of Galleri and other Grail products. His responsibilities also include identifying clinical trial sites and providing education on Grail's diagnostic platform to help physicians understand multicancer early detection.

Prior to his current role, Dr. McHenry was the medical science liaison director for NET and other radiosensitive tumors at Novartis Oncology in New York from 2021 to 2023. Here, he contributed significantly to new treatment paradigms for prostate cancer. Before this, he served as a medical science liaison at Advanced Accelerator Applications from 2020 to 2021 and held a similar position at Genentech from 2017 to 2020. At Genentech, he was involved in a landmark liver cancer combination trial that marked a significant shift in the clinical paradigm. His tenure at AstraZeneca as an oncology medical science liaison from 2015 to 2017, along with earlier roles as a research investigator at MetaStat from 2014 to 2015 and as a research scientist at Astellas Pharma from 2011 to 2013 laid the foundation for his expertise in oncology research.

Dr. McHenry's academic background is equally impressive. After receiving a Bachelor of Science in chemistry from the University of Dallas in 1997, he earned his PhD in biochemistry from the University of Illinois Chicago in 2006. After completing his postdoctoral fellowship at Harvard T.H. Chan School of Public Health in 2008, he was honored with a Presidential Postdoctoral Fellowship at Novartis Institutes for BioMedical Research in 2011.

As a member of the American Society of Clinical Oncology and the American Association for Cancer Research, Dr. McHenry continues to develop his expertise and strengthen his commitment to medical science. Outside of his professional life, he finds relaxation and fulfillment in hobbies such as coloring, Sudoku, gardening, and yard work. Looking ahead, Dr. McHenry aims to broaden his impact through mentorship programs and by embracing more leadership opportunities, continuing to contribute significantly to the field of oncology research while fostering the next generation of scientists and researchers.

# # #

Contact Information

-- --

Marquis Who's Who Ventures LLC

Uniondale, NY

USA

Telephone: 844-394-6946

Email: Email Us Here

Website: Visit Our Website

Follow Us: fb in x